 | • レポートコード：B-MOR-08289 • 出版社/出版日：Mordor Intelligence / 2018年6月29日 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（受注後2営業日） • 産業分類：Healthcare |
| Single User（1名様用） | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User（7名様用） | ￥666,000 (USD4,500) | ▷ お問い合わせ |
| Corporate User | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、眼内レンズの世界市場について調べ、眼内レンズの世界規模、市場動向、市場環境、製品タイプ別（単焦点眼内レンズ、調節型眼内レンズ、多焦点眼内レンズ、口腔内眼内レンズ）分析、エンドユーザー別（眼科医院、病院、通院外科診療所、研究機関）分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、企業の競争環境、関連企業情報などをまとめた調査レポートです。 ・イントロダクション ・エグゼクティブサマリー ・眼内レンズの世界市場インサイト ・眼内レンズの世界市場環境 ・眼内レンズの世界市場動向 ・眼内レンズの世界市場規模 ・眼内レンズの世界市場規模：製品タイプ別（単焦点眼内レンズ、調節型眼内レンズ、多焦点眼内レンズ、口腔内眼内レンズ） ・眼内レンズの世界市場規模：エンドユーザー別（眼科医院、病院、通院外科診療所、研究機関） ・眼内レンズの世界市場：地域別市場規模・分析 ・眼内レンズの北米市場規模・予測 ・眼内レンズのアメリカ市場規模・予測 ・眼内レンズのヨーロッパ市場規模・予測 ・眼内レンズのアジア市場規模・予測 ・眼内レンズの日本市場規模・予測 ・眼内レンズの中国市場規模・予測 ・眼内レンズのインド市場規模・予測 ・眼内レンズの韓国市場規模・予測 ・関連企業情報・競争状況 |
The global intraocular Lenses (IOLs) market is expected to register a growth rate of nearly 5% during the forecast period, 2018 to 2023. Intraocular lenses (IOLs) are implantable medical devices used for vision correction. Rising diabetic cases and associated cataract and diabetic retinopathy complications are expected to boost the global market.
Rising Ophthalmic Issues to Boost Market Growth
Rise in ocular conditions such as cataract, and diabetic retinopathy across the world is a major aspect assisting market growth. According to national eye institute, the United States recoded 7.7 million diabetic retinopathy cases, and 24 million cataract cases and expected to reach 11.3 million and 38 million respectively by 2030. In addition, the American Association of Ophthalmology states the major cause of visual impairment around the world is reported to be cataract, and geriatric ocular issues are emerging as prime factors in the developing countries. Hence, such a rise in the ophthalmic conditions across the globe is expected to drive the growth of the IOL market over the forecast period.
High Cost of Treatment to Hinder Market Growth
Higher costs associated with ophthalmic surgeries, such as cataract surgery, and other retinal correction surgeries are expected to drive the market growth over the forecast period. The cost of the IOL plays a vital role in the process of their adoption for vision correction or impairment surgeries. The approximate cost of an IOL implant surgery is USD 1,400 to USD 3,500 per eye.
In addition, the reimbursement is provided for IOL implants only in conditions where it is a necessity, and not in case of vision correction lenses, thereby increasing the financial burden on the patients. The cataract surgery in the United States costs around USD 3600 to USD 6600 without the insurance coverage. Thus, the increasing costs of IOLs and the poor reimbursement coverage are expected to hamper the market growth over the forecast period.
Asia-Pacific to Witness the Lucrative Growth
Rising incidences of cataract, diabetic retinopathy, and macular degeneration in the United States can be attributed to the dominance of the North America region IOL market in 2016. Moreover, presence of reimbursement policies for essential ophthalmic surgeries and a definite regulatory framework are enhancing growth in the market.
On the other hand, Asia-Pacific is expected to emerge as the fastest growing segment over the forecast period owing to government initiatives to include eye care in social security systems, rise in geriatric population, increasing cataract cases, and projected rise in diabetic population.
Diabetic patients are susceptible to macular degeneration, diabetic retinopathy, and cataract. Hence the increase in the diabetic population results in the rising need for IOLs. India accounted for a diabetic population of 50.8 million whereas the Eastern and Western Pacific regions accounted for 59 million and 77 million diabetic patients respectively according to the International Diabetes Federation.
The developing countries such as China, India, Malaysia, and Singapore are experiencing growth in the IOL market, owing to the growth in medical tourism industry and massive patient pool. In addition, the increasing initiatives of government and non-government organizations to provide affordable eye care in the Asia-Pacific region are expected to boost the market growth.
Key Developments in the Market
• October, 2017 – Alcon declared the introduction of its new intraocular lens (IOL) Clareon, at European Society for Cataract.
• October, 2017 – Alcon announced the completion of 100 million implants of its AcrySof IOL.
• October, 2017 – Alcon received CE mark for its product AutonoMe. This is a preloaded IOL delivery system containing Clareon IOL.
Major Players – ALCON INC., BAUSCH & LOMB INCORPORATED, CARL ZEISS MEDITEC AG, EYEKON MEDICAL INC., HOYA CORPORATION, HUMANOPTICS AG, JOHNSON AND JOHNSON VISION CARE INC., LENSTEC, INC. AND STAAR SURGICAL COMPANY, amongst others.
Reasons to Purchase this Report
• The current and future outlook of the intraocular lenses (IOLs) market in the developed and emerging markets
• Analysis of various perspectives of the market with the help of Porter’s five forces analysis
• Information regarding the segment that is expected to dominate the market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, market shares, and strategies employed by the major market players
• 3-month analyst support, along with the Market Estimate sheet (in excel)
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs
レポート目次1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter’s Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Products and Services
5.2.5 Competitive Rivalry within the Industry
5.3 Pipeline Analysis
5.4 Regulatory Scenario
6. Market Dynamics
6.1 Market Drivers
6.1.1 Rising Ophthalmic Issues
6.1.2 Increasing Cases of Cataract in Diabetic Population
6.1.3 Rising Adoption of Advanced Premium IOLs
6.2 Market Restraints
6.2.1 High costs of IOLs
6.2.2 Lack of Reimbursement Policies
6.3 Opportunities
6.4 Key Challenges
7. Market Segmentation
7.1 By Product Type
7.1.1 Monofocal Intraocular Lenses
7.1.2 Accomodative Intraocular Lenses
7.1.3 Multifocal Inraocular Lenses
7.1.4 Toric Intraocular Lenses
7.2 By End User
7.2.1 Ophthalmic Clinics
7.2.2 Hospitals
7.2.3 Ambulatory Clinics
7.2.4 Research Institutes
7.3 By Geography
7.3.1 North America
7.3.1.1 United States
7.3.1.2 Canada
7.3.1.3 Mexico
7.3.2 Europe
7.3.2.1 France
7.3.2.2 Germany
7.3.2.3 United Kingdom
7.3.2.4 Italy
7.3.2.5 Spain
7.3.2.6 Rest of Europe
7.3.3 Asia-Pacific
7.3.3.1 China
7.3.3.2 Japan
7.3.3.3 India
7.3.3.4 Australia
7.3.3.5 South Korea
7.3.3.6 Rest of Asia-Pacific
7.3.4 Middle East & Africa
7.3.4.1 GCC
7.3.4.2 South Africa
7.3.4.3 Rest of Middle East & Africa
7.3.5 South America
7.3.5.1 Brazil
7.3.5.2 Argentina
7.3.5.3 Rest of South America
8. Competitive Landscape
8.1 Merger & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key Players
9.1 Alcon Inc.
9.2 Bausch & Lomb Incorporated
9.3 Carl Zeiss Meditec AG
9.4 EyeKon Medical Inc.
9.5 Hoya Corporation
9.6 HumanOptics AG
9.7 Johnson and Johnson Vision Care Inc.
9.8 Lenstec Inc.
9.9 Rayner
9.10 STAAR Surgical Company
*List Not Exhaustive
10. Future of the Market